VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

VJVirtual | Bendamustine with dexamethasone in R/R systemic AL amyloidosis

Raymond Comenzo MD, of Tufts University School of Medicine, Boston, MA, outlines the use of bendamustine with dexamethasone, as an alternative, well-tolerated therapy in relapsed/refractory (R/R) systemic light-chain (AL) amyloidosis. This interview was recorded via an online conference call with the Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter